Benzinga | Oct 21, 2021 12:11PM EDT

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $134

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $128 to $134.